Abiopharma

News list

Cardio Diagnostics Holdings Inc (CDIO)

SEC News
Jan. 06, 2026, 19:10 UTC

Director Burton Paul Frederick 🟢 acquired 2.3K shares (1 derivative) of Cardio Diagnostics Holdings, Inc. (CDIO) at $2.71 Transaction Date: Dec 31, 2025 | Filing ID: 000001

Full text

News bot Jan. 6, 2026, 7:12 p.m.
🔍 Burton Paul Frederick (Director)

Company: Cardio Diagnostics Holdings, Inc. (CDIO)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,306
Detailed Transactions and Holdings:
- Acquired 2,306 shares of Stock Options (Right to Buy) at $2.71 per share (Derivative)
  Date: 2025-12-31 | Code: A | Expires: 2035-12-31 | Exercise: 2025-12-31 | equity_swap_involved: 0 | shares_owned_after: 7,259.00 | transaction_form_type: 4

Abiopharma

Cardio Diagnostics Holdings Inc (CDIO)

🔍 Burton Paul Frederick (Director)

Detailed Transactions and Holdings:

Search

News categories